Alessandra Gennari
- Oncology top 1%
- Cancer Treatment and Pharmacology 56
- HER2/EGFR in Cancer Research 22
- Cancer Risks and Factors 15
- Colorectal Cancer Treatments and Studies 10
- Cancer Research top 1%
- Breast Cancer Treatment Studies 32
-
- Chemotherapy-induced cardiotoxicity and mitigation 16
-
- Advanced Breast Cancer Therapies 19
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 15
- Co-authors
- Matteo PuntoniPierfranco ContéAndrea DeCensiPaolo BruzziBernardo BonanniMassimiliano CazzanigaSara GandiniPamela J. Goodwin
- Journals
- Journal of Clinical Oncology (28 papers)Annals of Oncology (13 papers)Cancer Research (8 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Alessandra Gennari
153 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 2.4k
- Cancer Research 1.2k
- Cardiology and Cardiovascular Medicine 687
- Pulmonary and Respiratory Medicine 773
- Molecular Biology 1.5k
Countries citing papers authored by Alessandra Gennari
This map shows the geographic impact of Alessandra Gennari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Gennari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Gennari more than expected).
Fields of papers citing papers by Alessandra Gennari
This network shows the impact of papers produced by Alessandra Gennari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Gennari. The network helps show where Alessandra Gennari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alessandra Gennari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 16 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 32 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 34 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 34 | |
| 11 | 2021 | 3 | |
| 12 | 2019 | 40 | |
| 13 | 2012 | 195 | |
| 14 | Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysisbreakdown → | 2010 | 713 |
| 15 | 2009 | 9 | |
| 16 | 2007 | 258 | |
| 17 | 2004 | 29 | |
| 18 | 2002 | 47 | |
| 19 | Epirubicin/taxane combinations in breast cancer: experience from several Italian trials. | 2001 | 3 |
| 20 | New combinations with epirubicin in advanced breast cancer. | 2001 | 3 |
About Alessandra Gennari
Alessandra Gennari is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 164 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (56 papers), Breast Cancer Treatment Studies (32 papers), HER2/EGFR in Cancer Research (22 papers), Advanced Breast Cancer Therapies (19 papers), Chemotherapy-induced cardiotoxicity and mitigation (16 papers), Metabolism, Diabetes, and Cancer (15 papers), Cancer Risks and Factors (15 papers) and Colorectal Cancer Treatments and Studies (10 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.2k citations) and Cardiology and Cardiovascular Medicine (687 citations). Alessandra Gennari has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Matteo Puntoni, Pierfranco Conté, Andrea DeCensi, Paolo Bruzzi, Bernardo Bonanni, Massimiliano Cazzaniga, Sara Gandini, Pamela J. Goodwin, Cinzia Orlandini and Paola Mattei. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Cancer Research and Treatment and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.